Comparison of the Efficacy, Toxicity, and Pharmacokinetics of a Uracil/Tegafur (UFT) Plus Oral Leucovorin (LV) Regimen Between Japanese and American Patients With Advanced Colorect... von SHIRAO, K, HOFF, P. M, BOKU, N, NAGASHIMA, F, ABBRUZZESE, J. L, OHTSU, A, LOEHRER, P. J, HYODO, I, WADLER, S, WADLEIGH, R. G, O'DWYER, P. J, MURO, K, YAMADA, Y

Volltext

Multi-institutional Phase II Trial of Induction Cetuximab Gemcitabine and Oxaliplatin, followed by Radiotherapy with Concurrent Capecitabine, and Cetuximab, for Locally Advanced Pa... von Crane, C.H, Varadhachary, G, Javle, M, Safran, H, Krishnan, S, Fleming, J, Das, P, Lee, J, Abbruzzese, J.L, Wolff, R.A

Volltext

Cetuximab (C225) Plus Cisplatin (CDDP) Irinotecan (CPT11) and Thoracic Radiotherapy (TRT) Definitive Treatment for Locally-advanced, Clinically Unresectable Esophageal Cancer: A So... von Thomas, C.R, Goldman, B.H, Benedetti, J.K, Lenz, H.J, Baker, T.A, Hammond-Thelin, L, Mehta, V.K, Fenoglio-Preiser, C.M, Abbruzzese, J.L, Blanke, C.D

Volltext

Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial von Kaseb, A.O., Garrett-Mayer, E., Morris, J.S., Xiao, L., Lin, E., Onicescu, G., Hassan, M.M., Hassabo, H.M., Iwasaki, M., Deaton, F.L., Abbruzzese, J.L., Thomas, M.B.

Volltext

1002 TGF-β-activated kinase 1 (TAK1) is an in vivo druggable target for reverting pancreatic cancer chemoresistance von Melisi, D, Xia, Q, Abbruzzese, J.L, Chiao, P.J

Volltext

P66 von Hwang, R.F, Wang, H, Lara, A, Gomez, H, Pomes, K, Chang, T, Abbruzzese, J.L, Evans, D.B

Volltext

NCI 9922: Phase II study of ibrutinib in treatment-refractory distant metastatic cutaneous melanoma (DMCM) von Moschos, S.J., Eroglu, Z., Khushalani, N.I., Kendra, K.L., Ansstas, G., In, G.K., Wang, P., Liu, G., Collichio, F.A., Arrowood, C.C., Reed, J.E., Garrett-Mead, N., Thomas, N.E., Ollila, D.W., Ivy, S.P., Ivanova, A., Dees, E.C., Abbruzzese, J.L.

Volltext

Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells von Sui, X, Shin, S, Zhang, R, Firozi, P F, Yang, L, Abbruzzese, J L, Reddy, S A G

Volltext

Phase II trial of docetaxel (Taxotere®) in metastatic colorectal carcinoma von Pazdur, R., Lassere, Y., Soh, L. T., Ajani, J. A., Bready, B., Soo, E., Sugarman, S., Patt, Y., Abbruzzese, J. L., Levin, B.

Volltext

Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors von Touroutoglou, N., Gravel, D., Raber, M. N., Plunkett, W., Abbruzzese, J. L.

Volltext

P66: An integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer von Hwang, R.F., Wang, H., Lara, A., Gomez, H., Pomes, K., Chang, T., Abbruzzese, J.L., Evans, D.B.

Volltext

Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study von Rothenberg, M. L., Benedetti, J. K., Macdonald, J. S., Seay, T. E., Neubauer, M. A., George, C. S., Tanaka, M. S., Giguere, J. K., Pruitt, B. T., Abbruzzese, J. L.

Volltext

RhuMab VEGF (bevacizumab) with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer: An active, well tolerated regimen von Crane, C.H., Ellis, L.M., OReilly, M., Ho, L., Abbruzzese, J.L., Evans, D.B., Ng, C., Charnsangavej, C., Tamm, E.P., Xiong, H.Q., Delclos, M.E., Wolff, R.A.

Volltext

Joint United States of America (USA)/Japan study of UFT (uracil and tegafur) plus leucovorin (LV) in patients (pts) with metastatic colorectal cancer (CRC) von Hoff, P.M., Loehrer, P., Abbruzzese, J.L., Ohtsu, A., Hyodo, I., Shirao, K.

Volltext

Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-FU- based chemoradiation in locally advanced pancreatic cancer von Crane, C.H., Wolff, R.A., Abbruzzese, J.L., Evans, D.B., Ballo, M., Delclos, M., Wong, A., Phan, T., Pisters, P.W., Janjan, N.A.

Volltext

Detection of primary breast cancer presenting as metastatic carcinoma of unknown primary origin by 111In-pentetreotide scan von LENZI, R, KIM, E. E, RABER, M. N, ABBRUZZESE, J. L

Volltext

Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloro platinum in patients with metastatic carcinoma of unknown primary origin von Raber, M. N., Faintuch, J., Abbruzzese, J. L., Sumrall, C., Frost, P.

Volltext

980 Preliminary results of a phase I study of rhumab VEGF (bevacizumab) with concurrent radiotherapy (XRT) and capecitabine (CAP) in locally advanced pancreatic cancer von Crane, C.H., Ellis, L.M., Xiong, H.Q., O'Reilly, M., Delclos, M.E., Abbruzzese, J.L., Evans, D.B., Pisters, P.W.T., Wolff, R.A.

Volltext

Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma von Moore, D. F., Pazdur, R., Abbruzzese, J. L., Ajani, J. A., Dubovsky, D. W., Wade, J. L., Belt, R. J., Mangold, C., Bready, B., Winn, R. J.

Volltext

Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells von Sui, X, Shin, S, Zhang, R, Firozi, P.F, Yang, L, Abbruzzese, J.L, Reddy, S.A.G

Volltext